Internal Medicine, Allergy & Immunology · Brooklyn, NY
NPI
1417986878
Since 2006
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3065 Brighton 14th St
Brooklyn, NY, 11235
Phone (718) 368-3889
Groups this clinician bills Medicare through
Medicare paid, 2024
$284K
6,508 services
Medicare patients, 2024
331
Average age 79
Drug cost, 2024
$3.7M
20,206 prescriptions
Company payments, 2025
$4,461
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dina Liberman was code 99213 (office e&m - established), 1,107 times for 315 patients. In total Dina Liberman billed 6,508 services in 61 codes, and Medicare paid $284K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,107 | 315 | $81.37 | $90K |
| 95165 Treatment - Miscellaneous | Office | 740 | 11 | $13.70 | $10K |
| 95024 Test - Miscellaneous | Office | 472 | 12 | $7.62 | $3,598 |
| 36415 Venipuncture Blood Collection | Office | 383 | 223 | $8.65 | $3,313 |
| 99442 Telephone Services | Office | 278 | 133 | $80.16 | $22K |
| 95117 Treatment - Miscellaneous | Office | 246 | 12 | $11.70 | $2,878 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 214 | 134 | $28.33 | $6,063 |
| 99497 Care Management/Coordination | Office | 185 | 184 | $89.75 | $17K |
| 96372 Injection Administration | Office | 161 | 65 | $12.97 | $2,088 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 158 | 158 | $146.85 | $23K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 152 | 152 | $21.63 | $3,288 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 147 | 147 | $21.64 | $3,181 |
| 99212 Office E&M - Established | Office | 146 | 108 | $50.89 | $7,430 |
| 82247 Clinical Chemistry | Office | 136 | 109 | $4.92 | $669 |
| 82010 Clinical Chemistry | Office | 136 | 109 | $8.01 | $1,089 |
By year: 2022 $290K for 6,809 services; 2023 $301K for 6,469 services; 2024 $284K for 6,508 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 383 | 223 | $8.65 | $3,313 |
| 81003 Clinical Chemistry | 136 | 109 | $2.20 | $299 |
| 82010 Clinical Chemistry | 136 | 109 | $8.01 | $1,089 |
| 82247 Clinical Chemistry | 136 | 109 | $4.92 | $669 |
| 83986 Clinical Chemistry | 136 | 109 | $3.51 | $477 |
Medicare prescription drug claims, 2024
In 2024, the drug Dina Liberman prescribed most often to Medicare patients was Rosuvastatin Calcium, with 635 prescriptions and refills. In total Dina Liberman wrote 20,206 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 635 | 795 | 103 | $2,309 |
| Metoprolol Succinate Generic | 564 | 701 | 84 | $4,374 |
| Amlodipine Besylate Generic | 527 | 654 | 90 | $1,359 |
| Vascepa Icosapent Ethyl | 471 | 514 | 67 | $173K |
| Synthroid Levothyroxine Sodium | 367 | 437 | 53 | $18K |
| Atorvastatin Calcium Generic | 367 | 465 | 62 | $1,407 |
| Linzess Linaclotide | 363 | 381 | 51 | $197K |
| Losartan Potassium Generic | 359 | 443 | 63 | $1,001 |
| Metformin Hcl Generic | 347 | 488 | 59 | $1,022 |
| Diclofenac Sodium Generic | 316 | 327 | 65 | $77K |
| Fluticasone Propionate Generic | 307 | 337 | 100 | $2,120 |
| Creon Lipase/Protease/Amylase | 298 | 332 | 51 | $468K |
| Carvedilol Generic | 285 | 315 | 39 | $851 |
| Omeprazole Generic | 279 | 325 | 51 | $1,058 |
| Eliquis Apixaban | 278 | 310 | 41 | $190K |
Brand drugs: 5,749 claims; generic drugs: 14,050 claims; opioid claims: 178.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dina Liberman $4,461 ($4,461 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $1,588.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $1,588 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $523 |
| Amgen Inc. AMGN | 10 | $519 |
| Axsome Therapeutics, Inc. AXSM | 7 | $375 |
| Aimmune Therapeutics, Inc. | 5 | $346 |
| Sumitomo Pharma America, Inc. 4506.T | 17 | $269 |
| Novo Nordisk Inc NVO | 5 | $206 |
| Kowa Pharmaceuticals America, Inc. | 2 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $85.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.